Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications (Q28239980)

Human Reproduction Update

PubMed

published in

1 reference

Cryopreservation of ovarian tissue for fertility preservation in young female oncological patients

PubMed

cites work

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Pretreatment serum anti-müllerian hormone predicts long-term ovarian function and bone mass after chemotherapy for early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Antimüllerian hormone, the assessment of the ovarian reserve, and the reproductive outcome of the young patient with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Premenopausal antimüllerian hormone concentration is associated with subsequent atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Serum anti-mullerian hormone levels and follicular cohort characteristics after pituitary suppression in the late luteal phase with oral contraceptive pills.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Natural mutations of the anti-Mullerian hormone type II receptor found in persistent Mullerian duct syndrome affect ligand binding, signal transduction and cellular transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Ovarian antral follicle subclasses and anti-mullerian hormone during normal reproductive aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Impact of previous uterine artery embolization on fertility

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Antimüllerian hormone levels are strongly associated with live-birth rates after assisted reproduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Ovarian aging: mechanisms and clinical consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Anti-mullerian hormone predicts menopause: a long-term follow-up study in normoovulatory women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Prediction of an excessive response in in vitro fertilization from patient characteristics and ovarian reserve tests and comparison in subgroups: an individual patient data meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Anti-Müllerian hormone is a marker of gonadotoxicity in pre- and postpubertal girls treated for cancer: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Elevated body mass index is associated with lower serum anti-mullerian hormone levels in infertile women with diminished ovarian reserve but not with normal ovarian reserve.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Anti-Müllerian hormone levels in peripubertal daughters of women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

The level of serum anti-Müllerian hormone correlates with vitamin D status in men and women but not in boys

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Antimüllerian hormone serum levels: a putative marker for ovarian aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Primary ovarian insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Menopausal status and adjuvant hormonal therapy for breast cancer patients: a practical guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Pretreatment antimüllerian hormone levels determine rate of posttherapy ovarian reserve recovery: acute changes in ovarian reserve during and after chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Reproductive and lifestyle determinants of anti-Müllerian hormone in a large population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Anti-Mullerian hormone in the diagnosis of polycystic ovary syndrome: can morphologic description be replaced?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Serum anti-Müllerian hormone dynamics during controlled ovarian hyperstimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Predictors of ovarian response: progress towards individualized treatment in ovulation induction and ovarian stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Can anti-Müllerian hormone concentrations be used to determine gonadotrophin dose and treatment protocol for ovarian stimulation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Association of anti-mullerian hormone levels with obesity in late reproductive-age women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Anti-mullerian hormone as a predictor of time to menopause in late reproductive age women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Anti-Müllerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Fertility of tall girls treated with high-dose estrogen, a dose-response relationship.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

An immunoassay to detect human müllerian inhibiting substance in males and females during normal development

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Can anti-Mullerian hormone predict the diagnosis of polycystic ovary syndrome? A systematic review and meta-analysis of extracted data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Limited value of ovarian function markers following orthotopic transplantation of ovarian tissue after gonadotoxic treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

The optimum number of oocytes in IVF treatment: an analysis of 2455 cycles in China.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

An Enzyme Linked Immunoassay for Anti-Müllerian Hormone: A New Tool for the Evaluation of Testicular Function in Infants and Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

AMH and AMH receptor defects in persistent Müllerian duct syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

A validated model of serum anti-müllerian hormone from conception to menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

A polymorphism in the AMH type II receptor gene is associated with age at menopause in interaction with parity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Expected poor responders on the basis of an antral follicle count do not benefit from a higher starting dose of gonadotrophins in IVF treatment: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Anti-Mullerian hormone, inhibin B, and antral follicle count in young women with ovarian failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

The association between circulating levels of antimüllerian hormone and follicle number, androgens, and menstrual cycle characteristics in young women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

The Anti-Mullerian hormone and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Primary ovarian insufficiency due to steroidogenic cell autoimmunity is associated with a preserved pool of functioning follicles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Development of a nomogram based on markers of ovarian reserve for the individualisation of the follicle-stimulating hormone starting dose in in vitro fertilisation cycles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Prediction of age at menopause from assessment of ovarian reserve may be improved by using body mass index and smoking status

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Anti-Müllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

High frequency of discordance between antimüllerian hormone and follicle-stimulating hormone levels in serum from estradiol-confirmed days 2 to 4 of the menstrual cycle from 5,354 women in U.S. fertility centers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Anti-Mullerian-hormone-dependent regulation of the brain serine-protease inhibitor neuroserpin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Measurements of serum müllerian inhibiting substance in the evaluation of children with nonpalpable gonads.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Increased gonadotrophin stimulation does not improve IVF outcomes in patients with predicted poor ovarian reserve.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Serum anti-müllerian hormone levels in healthy females: a nomogram ranging from infancy to adulthood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Serum anti-Müllerian hormone, inhibin B, and total inhibin levels in women with hypothalamic amenorrhea and anorexia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Circulating vitamin D correlates with serum antimüllerian hormone levels in late-reproductive-aged women: Women's Interagency HIV Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Changes in anti-Müllerian hormone serum concentrations over time suggest delayed ovarian ageing in normogonadotrophic anovulatory infertility

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

The journey from the old to the new AMH assay: how to avoid getting lost in the values

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Nomogram for the decline in serum antimüllerian hormone: a population study of 9,601 infertility patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

A 10-year follow up of reproductive function in women treated for childhood cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Individualizing FSH dose for assisted reproduction using a novel algorithm: the CONSORT study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Intra-cycle fluctuations of anti-Müllerian hormone in normal women with a regular cycle: a re-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

A prospective randomized clinical trial comparing an individual dose of recombinant FSH based on predictive factors versus a 'standard' dose of 150 IU/day in 'standard' patients undergoing IVF/ICSI treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Testing and interpreting measures of ovarian reserve: a committee opinion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Markers of ovarian reserve in young girls with Turner's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

The impact of excision of ovarian endometrioma on ovarian reserve: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Anti-Mullerian hormone: poor assay reproducibility in a large cohort of subjects suggests sample instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

The anti-Müllerian hormone type II receptor: insights into the binding domains recognized by a monoclonal antibody and the natural ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Genetic variants and environmental factors associated with hormonal markers of ovarian reserve in Caucasian and African American women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Variations in serum müllerian inhibiting substance between white, black, and Hispanic women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Serum antimüllerian hormone in healthy premenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Effects of birth weight on anti-mullerian hormone serum concentrations in infant girls

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Anti-Mullerian hormone and inhibin B levels as markers of premature ovarian aging and transition to menopause in type 1 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Antimullerian hormone and obesity: insights in oral contraceptive users

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Antimüllerian hormone as a predictor of natural fecundability in women aged 30-42 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Serum antimüllerian hormone levels remain stable throughout the menstrual cycle and after oral or vaginal administration of synthetic sex steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Body size affects measures of ovarian reserve in late reproductive age women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

The impact of depot GnRH agonist on AMH levels in healthy reproductive-aged women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

The variability of female reproductive ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Is polycystic ovary syndrome an exception for reproductive aging?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

The effect of weight loss on anti-Müllerian hormone levels in overweight and obese women with polycystic ovary syndrome and reproductive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

The role of anti-müllerian hormone (AMH) in assessing ovarian reserve

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Comparison of ovarian function markers in users of hormonal contraceptives during the hormone-free interval and subsequent natural early follicular phases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Optimum number of oocytes for a successful first IVF treatment cycle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Comparison of inter- and intra-cycle variability of anti-Mullerian hormone and antral follicle counts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Predictors of recovery of ovarian function during weight gain in anorexia nervosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

The OPTIMIST study: optimisation of cost effectiveness through individualised FSH stimulation dosages for IVF treatment. A randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Increased oocyte degeneration and follicular atresia during the estrous cycle in anti-Müllerian hormone null mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Anti-Müllerian hormone levels in girls and adolescents with Turner syndrome are related to karyotype, pubertal development and growth hormone treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

A multicentre evaluation of the new Beckman Coulter anti-Mullerian hormone immunoassay (AMH Gen II).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Evidence for a Müllerian-inhibiting substance autocrine/paracrine system in adult human endometrium

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

A single-centre evaluation of two new anti-Mullerian hormone assays and comparison with the current clinical standard assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Anti-Mullerian hormone-tailored stimulation protocols improve outcomes whilst reducing adverse effects and costs of IVF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Within-laboratory and between-laboratory variability in the measurement of anti-müllerian hormone determined within an external quality assurance scheme

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Serum Levels of Anti-Müllerian Hormone as a Marker of Ovarian Function in 926 Healthy Females from Birth to Adulthood and in 172 Turner Syndrome Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Serum levels of antimüllerian hormone in early maturing girls before, during, and after suppression with GnRH agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Low concentration of circulating antimüllerian hormone is not predictive of reduced fecundability in young healthy women: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

The Relationship Between Anti-Müllerian Hormone in Women Receiving Fertility Assessments and Age at Menopause in Subfertile Women: Evidence From Large Population Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020

Induction of puberty by autograft of cryopreserved ovarian tissue in a patient previously treated for Ewing sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU020